Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco Spinoff Plan Revised; PBM Margins Look Healthier In 2003

Executive Summary

The one-year delay in Merck's Medco spinoff means that the pharmacy benefit manager will begin operations as a separately traded public company with a healthier gross margin

You may also be interested in...



Medco Is Meeting Merck Market Share Targets; Spin-Off Plan Moves Ahead

Merck's market share within the Medco customer base is running about 33% higher than the company's overall national market share

Medco Is Meeting Merck Market Share Targets; Spin-Off Plan Moves Ahead

Merck's market share within the Medco customer base is running about 33% higher than the company's overall national market share

Medco Lets Snow Reign: CEO David Snow Joins PBM From WellChoice

Medco Health's separation from Merck will be overseen by former WellChoice Chief Operating Officer David Snow

UsernamePublicRestriction

Register

PS017586

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel